Compare LLY & AMZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LLY | AMZN |
|---|---|---|
| Founded | 1876 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 979.6B | 2.6T |
| IPO Year | 2007 | 1997 |
| Metric | LLY | AMZN |
|---|---|---|
| Price | $1,247.92 | $261.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 19 | 42 |
| Target Price | ★ $1,218.84 | $285.88 |
| AVG Volume (30 Days) | 2.1M | ★ 41.7M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | ★ 0.81% | N/A |
| EPS Growth | ★ 95.99 | 29.66 |
| EPS | ★ 16.19 | 8.53 |
| Revenue | $65,179,000,000.00 | ★ $716,924,000,000.00 |
| Revenue This Year | $27.15 | $14.63 |
| Revenue Next Year | $16.04 | $11.81 |
| P/E Ratio | $77.50 | ★ $30.32 |
| Revenue Growth | ★ 44.70 | 12.38 |
| 52 Week Low | $712.05 | $196.00 |
| 52 Week High | $1,292.65 | $287.20 |
| Indicator | LLY | AMZN |
|---|---|---|
| Relative Strength Index (RSI) | 58.01 | 52.53 |
| Support Level | $1,135.68 | $222.85 |
| Resistance Level | N/A | $276.66 |
| Average True Range (ATR) | 41.24 | 5.93 |
| MACD | 5.56 | -1.47 |
| Stochastic Oscillator | 71.02 | 19.58 |
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Amazon is the leading online retailer and marketplace for third party sellers. Retail related revenue represents approximately 74% of total, followed by Amazon Web Services (17%), and advertising services (9%). International segments constitute 22% of Amazon's total revenue, led by Germany, the United Kingdom, and Japan.